Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

PROGNOSTIC VALUE OF ELEVATED LEVELS OF INTESTINAL MICROFLORA-GENERATED METABOLITE TRIMETHYLAMINE N-OXIDE IN PATIENTS WITH HEART FAILURE: THE GUT HYPOTHESIS REVISITED

29.10.20141783
Accumulation of intestinal microbial-dependent dietary phosphatidylcholine metabolite, trimethylamine N-oxide (TMAO), has been associated with coronary artery disease (CAD) pathogenesis.

Platelet Activation Is Associated With Myocardial Infarction in Patients With Pneumonia

28.10.20141603
What is the interplay between platelet overactivation and cardiovascular events during pneumonia?

Is There any Difference in Cardiogoniometry Parameters of Ischemic and Nonischemic Cardiomyopathy in Patients with Left Bundle Branch Block?

27.10.20141595
Differentiating ischemic from nonischemic cardiomyopathy is important both prognostically and therapeutically, although it may be difficult clinically.

Sotalol hydrochloride approved for treatment of ventricular arrhythmias, maintenance of normal sinus rhythm

25.10.20141659
Arbor Pharmaceuticals announced that the FDA has approved a new drug application for sotalol hydrochloride oral solution for the treatment of documented life-threatening ventricular arrhythmias and the maintenance of normal sinus rhythm in patients with a history of highly symptomatic atrial fibrillation or flutter.

Use of Coumarin Anticoagulants and Cerebral Microbleeds in the General Population

24.10.20141934
Does the use of warfarin relate to a higher prevalence and incidence of cerebral microbleeds?

Electrophysiologic Substrate in Congenital Long QT Syndrome: Noninvasive Mapping with Electrocardiographic Imaging (ECGI)

22.10.20141509
Congenital Long QT syndrome (LQTS) is an arrhythmogenic disorder that causes syncope and sudden death.

Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction

21.10.20141731
What is the potential role of Subtance P (SP) in acute myocardial infarction (AMI) and its association with major adverse cardiac events (MACE) such as death, heart failure (HF), or reinfarction?
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.